Related Experiment Video
Updated: Feb 4, 2026
08:32
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish
Published on: February 22, 2019
7.5K
[Radionuclide teranostic of malignancies]
Vestnik Rentgenologii I Radiologii
|September 25, 2018
Summary
This review introduces theranostics, a promising field combining diagnosis and therapy. It explores radioisotope selection and the use of monoclonal antibodies for targeted radionuclide theranostics.
Area of Science:
- Nuclear medicine and molecular imaging
- Oncology
- Radiopharmaceutical science
Background:
- Theranostics integrates diagnostic and therapeutic applications in medicine.
- Emerging field with significant potential for personalized treatment strategies.
- Requires careful selection of imaging and therapeutic agents.
Purpose of the Study:
- To provide an overview of the principles of theranostics.
- To discuss the selection of radioisotopes for diagnostic and therapeutic purposes.
- To highlight the role of monoclonal antibodies in radionuclide theranostics.
Main Methods:
- Review of current literature on theranostics.
- Analysis of radioisotope selection criteria for combined imaging and therapy.
- Examination of strategies utilizing monoclonal antibodies for targeted radionuclide delivery.
Main Results:
- Theranostics offers a personalized approach by combining diagnostic imaging with targeted radionuclide therapy.
- Radioisotope selection is critical for optimizing both diagnostic accuracy and therapeutic efficacy.
- Monoclonal antibodies serve as key targeting vectors in radionuclide theranostics, enabling precise delivery to disease sites.
Conclusions:
- Theranostics represents a rapidly advancing frontier in nuclear medicine.
- Optimized radioisotope and antibody selection are crucial for successful theranostic applications.
- This approach holds significant promise for improving patient outcomes in various diseases.
Related Concept Videos
02:48Radioactive Decay and Radiometric Dating
37.2K
Radioactivity is a spontaneous disintegration of an unstable nuclide and is a random process, as all the nuclei in the sample do not decay simultaneously. The number of disintegrations per unit time is called the activity (A), which is directly proportional to the number of nuclei in the sample. The decay constant (λ) is an average probability of decay per nucleus in unit time.
37.2K
03:18Nuclear Stability
23.3K
Protons and neutrons, collectively called nucleons, are packed together tightly in a nucleus. With a radius of about 10−15 meters, a nucleus is quite small compared to the radius of the entire atom, which is about 10−10 meters. Nuclei are extremely dense compared to bulk matter, averaging 1.8 × 1014 grams per cubic centimeter. If the earth’s density were equal to the average nuclear density, the earth’s radius would be only about 200 meters.
To hold positively charged protons together...
To hold positively charged protons together...
23.3K
03:18Radioactivity and Nuclear Equations
27.4K
Nuclear chemistry is the study of reactions that involve changes in nuclear structure. The nucleus of an atom is composed of protons and, except for hydrogen, neutrons. The number of protons in the nucleus is called the atomic number (Z) of the element, and the sum of the number of protons and the number of neutrons is the mass number (A). Atoms with the same atomic number but different mass numbers are isotopes of the same element.
A nuclide of an element has a specific number of protons and...
A nuclide of an element has a specific number of protons and...
27.4K
03:23Types of Radioactivity
19.7K
The most common types of radioactivity are α decay, β decay, γ decay, neutron emission, and electron capture.
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
Alpha (α) decay is the emission of an α particle from the nucleus. For example, polonium-210 undergoes α decay:
19.7K